Previous Page  12 / 24 Next Page
Information
Show Menu
Previous Page 12 / 24 Next Page
Page Background

E L E C T R O M A G N E T I C N A V I G A T I O N A L B R O N C H O S C O P Y

‘GPS’

for the

Lungs

By Stacie Jones

Lung cancer

is difficult to detect

early and is often not diagnosed

until the disease is in its advanced

stages, which greatly reduces

treatment options and a patient’s

chance of survival. A procedure

newly available at Kootenai Health

could help change that.

Todd Hoopman, M.D., of North

Idaho Lung, Asthma and Critical

Care, is a Kootenai affiliate pro-

vider who specializes in pulmonary

(lung) disease and is now offer-

ing electromagnetic navigational

bronchoscopy (ENB). The ad-

vanced procedure is used to locate

and biopsy abnormal masses in

areas of the lungs that traditional

bronchoscopy can’t reach.

“Navigational bronchoscopy is a

minimally invasive procedure that

reaches difficult areas of the lung

with great precision and accuracy,”

Dr. Hoopman said. “The technique

allows us to access and biopsy

nodules in regions of the lung that

cannot be safely reached with other

methods due to surrounding struc-

tures, blood vessels or lung tissue

affected by emphysema.”

In traditional bronchoscopy, a

thin, lighted tube called a bron-

choscope is used to navigate and

view airways. However, the bron-

choscope is too big to reach some

areas of the lungs. With ENB,

Dr. Hoopman uses a navigation

catheter, advanced imaging soft-

ware and other special tools to

extend beyond the bronchoscope’s

reach into the lungs’ outermost

regions. Dr. Hoopman likens the

procedure to GPS for the lungs.

A C C U R A T E D I A G N O S I S

ENB can be used to evaluate a

variety of lung diseases and is

especially valuable in the accurate

diagnosis of lung cancer.

“This technology gives physi-

cians the ability to more precisely

and accurately diagnose smaller

cancer nodules at an earlier stage,

which can help generate personal-

ized treatment options and improve

survival,” Dr. Hoopman said.

“Too many lung cancers, both

nationally and locally, are diag-

nosed in stages III and IV,” he

added. “This technology gives us

the potential to shift the time of

diagnosis to the more favorable

stages (I and II) and, in turn, save

lives.”

Kootenai Health is the first

hospital system in Idaho to offer

the newest version of the super-

dimension navigation bronchoscopy

system by Medtronic. Dr. Hoop-

man said the addition of the new

technology reflects Kootenai’s

commitment to providing the best

possible care for patients.

“The acquisition of this naviga-

tional bronchoscopy technology

completes Kootenai Health’s diag-

nostic and treatment modalities

for lung cancer and other cancers

of the chest,” he said. “Now

patients can get the comprehensive

care they need here at their local

hospital and not have to travel out

of the area for this cutting-edge

procedure.”

Todd Hoopman, M.D.

12